Iovance Biotherapeutics Inc. Common Stock vs MP Materials — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while MP Materials trades at $46.82 (market cap $8.25B). The key difference: MP Materials is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, MP Materials nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and MP Materials for 11 Days on average.
| IOVA | MP | |
|---|---|---|
Market Cap | $5.85B | $8.25B |
Volume | 14,517,176 | 5,934,023 |
Sector | Health | Basic Materials |
52-Week High | $14.82 | $98.65 |
52-Week Low | $1.81 | $38.10 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $5.78B | $7.73B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.
Read more on MP →